These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2102306)

  • 1. Tumor markers in ovarian carcinoma.
    Dudzinski MR
    Curr Opin Obstet Gynecol; 1990 Feb; 2(1):52-6. PubMed ID: 2102306
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor markers in the monitoring of ovarian cancer].
    Xu SX
    Zhonghua Fu Chan Ke Za Zhi; 1990 Nov; 25(6):345-7, 383. PubMed ID: 2282861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of some tumor markers in differential diagnosis of ovarian tumor.
    Zakrzewska I; Borawska R; Poznański J; Maćkowiak B
    Rocz Akad Med Bialymst; 1999; 44():235-43. PubMed ID: 10697438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor marker CA 72-4 in ovarian cancer in comparison with CA 125 and D-dimer].
    Schelling M; Jänicke F; Senekowitsch R; Lörken A
    Gynakol Rundsch; 1991; 31 Suppl 2():286-9. PubMed ID: 1665138
    [No Abstract]   [Full Text] [Related]  

  • 5. Power of chronobiologic pilots: a statistician's opinion.
    Berry DA
    Chronobiologia; 1993; 20(3-4):213-8. PubMed ID: 8131670
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
    Hasholzner U; Baumgartner L; Stieber P; Meier W; Hofmann K; Fateh-Moghadam A
    Anticancer Res; 1994; 14(6B):2743-6. PubMed ID: 7532929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor markers in epithelial ovarian cancer. Clinical applications.
    Hempling RE
    Obstet Gynecol Clin North Am; 1994 Mar; 21(1):41-61. PubMed ID: 8015766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of tumor-associated mucin-type glycoprotein CA 54/61 in ovarian cancers: comparison with CA 125.
    Suzuki M; Sekiguchi I; Tamada T
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):422-7. PubMed ID: 2381620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The CA-125 tumor marker in epithelial ovarian cancers of stage I].
    Nagele F; Vavra N; Kurz C; Sevelda P
    Wien Klin Wochenschr; 1993; 105(20):585-8. PubMed ID: 8259686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases].
    Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
    Gan To Kagaku Ryoho; 1994 May; 21(6):823-32. PubMed ID: 8185340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High CA-125 values in a patient with miliary tuberculosis and ascites].
    Klein M; Marczewski A; Rosen A; Beck A
    Gynakol Rundsch; 1989; 29 Suppl 2():355-6. PubMed ID: 2613049
    [No Abstract]   [Full Text] [Related]  

  • 12. [A clinical evaluation of the CA 72-4 serum level as a possible tumor marker].
    Jibiki K; Takeda M; Abe H; Ito M; Odagiri E; Demura R; Demura H; Takizawa K
    Gan No Rinsho; 1990 Oct; 36(12):2146-52. PubMed ID: 2232183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous measurement of CA 125, CA 19-9, tissue polypeptide antigen, and immunosuppressive acidic protein to predict recurrence of ovarian cancer.
    Kamiya N; Mizuno K; Kawai M; Kano T; Furuhashi Y; Tomoda Y
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):417-21. PubMed ID: 2381619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [STN (sialyl Tn antigen)].
    Kannagi R
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():659-62. PubMed ID: 16149605
    [No Abstract]   [Full Text] [Related]  

  • 15. [Detection of CA 125 in the serum and tissue of patients with ovarian neoplasms].
    Kristen P; Beier HJ; Kaesemann H; Caffier H
    Gynakol Rundsch; 1989; 29 Suppl 2():358-60. PubMed ID: 2693257
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination of markers may prove useful in screening for ovarian CA.
    Oncology (Williston Park); 1994 Jun; 8(6):79-80. PubMed ID: 8074986
    [No Abstract]   [Full Text] [Related]  

  • 17. Biomarkers and clinical trial design.
    Farley J; Bast RC; Birrer MJ
    Gynecol Oncol; 2006 Nov; 103(2 Suppl 1):S3-5. PubMed ID: 17027069
    [No Abstract]   [Full Text] [Related]  

  • 18. The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary data.
    Gadducci A; Ferdeghini M; Ceccarini T; Prontera C; Facchini V; Bianchi R; Fioretti P
    J Nucl Med Allied Sci; 1989; 33(1):32-6. PubMed ID: 2746365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].
    Nozawa S; Udagawa Y; Ito K; Susumu N; Sasaki H; Aoki D
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):279-85. PubMed ID: 8434967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical value of carbohydrate antigen 50 and carbohydrate antigen 242 in the diagnosis of colorectal carcinoma].
    Huang CW; Bai L
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1116-8. PubMed ID: 12480590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.